Directory
>
Daniel Patterson
Daniel Patterson
Vice President, Head of CMC, Biologics and Gene Therapies | Roivant Sciences
Raleigh, North Carolina, United States
Daniel Patterson
Summary
Daniel Patterson is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President and Head of CMC for Biologics and Gene Therapies at Roivant Sciences. With a Ph.D. in Organic Chemistry from Stanford University, he possesses a robust technical background in chemical engineering and drug development. His career spans over two decades, during which he has held various leadership positions at renowned companies such as GlaxoSmithKline and Cempra Pharmaceuticals. Daniel's expertise includes good manufacturing practices, project management, and validation processes, making him a key player in advancing pharmaceutical innovations. He is passionate about fostering talent and driving sustainability within the industry. His extensive experience in both startup and corporate environments showcases his versatility and adaptability in a rapidly evolving field. Daniel's commitment to excellence is evident in his strategic approach to product development and his ability to navigate complex regulatory landscapes.
Daniel Patterson
Work Experience
Vice President, Head of CMC, Biologics and Gene Therapies at
Roivant Sciences
April 2021 - Present
Head of CMC, Drug Substance at
Roivant Sciences
July 2018 - April 2021
Senior Director, Pharmaceutical Development at
Roivant Sciences
September 2017 - July 2018
Vice President of Chemistry, Manufacturing and Controls at
Cempra Pharmaceuticals
April 2015 - September 2017
Senior Scientific Investigator - 2nd Generation Product Development at
GSK
July 2012 - April 2015
Senior Scientific Investigator - API Chemistry and Analysis at
GSK
January 2010 - January 2012
Investigator - Chemical Development at
GSK
January 2004 - January 2010
Principal Scientist - Chemical Development at
GSK
November 2000 - January 2004
Daniel Patterson
Education
Stanford University, Ph.D.
January 1995 - January 2000
Williams College, Ba
January 1991 - January 1995
Frequently Asked Questions about Daniel Patterson
What is Daniel Patterson email address?
Daniel Patterson's primary email address is ***********@nc.rr.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Daniel Patterson work for?
Daniel Patterson is a Vice President, Head of CMC, Biologics and Gene Therapies at Roivant Sciences.
Where Daniel Patterson graduated from?
Daniel Patterson holds a degree in Organic Chemistry from Stanford University.
How can I directly contact Daniel Patterson?
To contact Daniel Patterson directly, you can use the email address ***********@nc.rr.com. Complete contact information is available upon registration with Muraena.
Who is Daniel Patterson?
Daniel Patterson is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President and Head of CMC for Biologics and Gene Therapies at Roivant Sciences. With a Ph.D. in Organic Chemistry from Stanford University, he possesses a robust technical background in chemical engineering and drug development. His career spans over two decades, during which he has held various leadership positions at renowned companies such as GlaxoSmithKline and Cempra Pharmaceuticals. Daniel's expertise includes good manufacturing practices, project management, and validation processes, making him a key player in advancing pharmaceutical innovations. He is passionate about fostering talent and driving sustainability within the industry. His extensive experience in both startup and corporate environments showcases his versatility and adaptability in a rapidly evolving field. Daniel's commitment to excellence is evident in his strategic approach to product development and his ability to navigate complex regulatory landscapes.
Daniel`s contact details
***********@nc.rr.com
****************@roivant.com
Colleagues
Chief Development Officer
Chief Communications Officer
Chief Financial Officer
Executive Director
VP, Special Projects, Office of CEO
Chief Executive Officer
Vice President, Head of CMC, Small Molecule Development
VP, Research
Board Member
Senior Vice President, Investments